stoxline Quote Chart Rank Option Currency Glossary
  
(QMN)
  0 (0%)    09-27 09:27
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2023-03-03 4:52:15 PM
Short term     
Mid term     
Targets 6-month :  29.17 1-year :  29.59
Resists First :  24.97 Second :  25.34
Pivot price 24.81
Supports First :  24.38 Second :  20.29
MAs MA(5) :  24.84 MA(20) :  24.75
MA(100) :  25.01 MA(250) :  25.42
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  80.8 D(3) :  87
RSI RSI(14): 46.7
52-week High :  26.63 Low :  24.38
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ QMN ] has closed below upper band by 36.7%. Bollinger Bands are 60.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 24.85 - 25 25 - 25.15
Low: 24.47 - 24.65 24.65 - 24.82
Close: 24.57 - 24.83 24.83 - 25.08
Company Description

Headline News

Mon, 22 Sep 2025
QMN: Monday Mixtape with Rachael Sage, Benjamin Elgar, Boys Don’t Fight and more - dallasvoice.com

Wed, 17 Sep 2025
PM Modi’s birthday marked with Seva Parv 2025, a digital service festival on NaMo App - Business Today

Mon, 04 Aug 2025
QMN: Monday Mixtape with Adam Lambert, Dagger Polyester and Black Polish - dallasvoice.com

Mon, 21 Jul 2025
QMN: Monday Mixtape with The Aces, Maren Morris, Gatlin and more - dallasvoice.com

Mon, 19 May 2025
Albumin Corona Overturns Long-Acting Behaviors of Myristic Acid-Conjugated Quetiapine Nanosuspension - Wiley

Mon, 19 May 2025
Albumin Corona Overturns Long-Acting Behaviors of Myristic Acid-Conjugated Quetiapine Nanosuspension - Wiley

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android